Most viewed in the last 7 days from JAMA Neurology: Does IV tirofiban reduce early neurological deterioration in patients with acute noncardioembolic stroke? https://ja.ma/4aTvsbr
JAMA Neurology
Book and Periodical Publishing
Chicago, Illinois 18,331 followers
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
About us
JAMA Neurology is published online weekly, every Monday, and in 12 print/online issues a year. The journal receives more than 7.7 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal’s acceptance rate is 9%. The median time to first decision is 5 days, and 35 days with review. The Journal Impact Factor is 29, one of the highest ranking among neurology journals. All articles are published online first. S. Andrew Josephson, MD, Professor of Neurology and Chair of the Department of Neurology, University of California, San Francisco, is the editor in chief.
- Website
-
https://jamanetwork.com/journals/jamaneurology
External link for JAMA Neurology
- Industry
- Book and Periodical Publishing
- Company size
- 1,001-5,000 employees
- Headquarters
- Chicago, Illinois
- Founded
- 1919
- Specialties
- Neurology
Updates
-
Surgical treatment may be beneficial in patients with large cerebellar infarcts, whereas conservative treatment may be reasonable in patients with lower infarct volumes. https://ja.ma/3J8wG6i
-
This study implicates activated glial measures, and GFAP in particular, as a CSF biomarker of nonrelapsing progressive MS biology and demonstrates commonalities of relapsing and nonrelapsing progressive disease mechanisms across the MS clinical spectrum. https://ja.ma/3PQgUAU
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
jamanetwork.com
-
A 24-year-old man presented with progressive gait instability, marked spinal cord atrophy, and dental radiography showing the absence of several elements, microdontia, and taurodontia. What is your diagnosis? https://ja.ma/3UcZz6H
A 24-Year-Old Man With Spastic Ataxia and Hypodontia
jamanetwork.com
-
Most viewed in the last 7 days from JAMA Neurology: Case report describes a 17-year-old boy with reduced consciousness and T2-weighted hyperintensity, focal diffusion restriction, and microhemorrhages within the deep gray nuclei and surrounding white matter. https://ja.ma/3VZpbXa
-
-
Case report describes a woman cold-induced reflex seizures. https://ja.ma/4dbTksz
-
-
Tirofiban decreased the risk of early neurological deterioration, but did not increase the risk of symptomatic intracerebral hemorrhage or systematic bleeding, in patients with acute ischemic stroke. https://ja.ma/3Qi6p9J
-
-
Most viewed in the last 7 days from JAMA Neurology: Case report describes a 17-year-old boy with reduced consciousness and T2-weighted hyperintensity, focal diffusion restriction, and microhemorrhages within the deep gray nuclei and surrounding white matter. https://ja.ma/3vY1hR8
-
-
In US hospitals participating in Get With The Guidelines–Stroke, earlier anticoagulation reversal was associated with improved survival for patients with intracerebral hemorrhage. #ISC24 https://ja.ma/4apij9H
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
jamanetwork.com
-
Most viewed in the last 7 days from JAMA Neurology: Is seizure prophylaxis associated with reduced risk for early posttraumatic seizures, defined as seizures within 7 days of injury, for patients with mild or moderate TBI? https://ja.ma/43XnTxZ
-